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Introduction
Extended spectrum β-lactamases (ESBLs) belong to a
wide group of enzymes named β-lactamases. A large
number of these enzymes and a need for their under-
standing caused that tries of their classification have
been undertaken. At present, two systems of β-lacta-
mases classification are commonly used. One based on
the molecular structure of the enzyme and the second
on their functional characteristics [1]. The presence of
serine at the active site in ESBLs classify them into A-
molecular class of Ambler scheme. Whereas, charac-
teristic activity properties caused classification of the
majority of ESBLs into 2be group whereby the Bush-
Jacoby-Medeiros scheme. Generally β-lactam
enzymes hydrolyze antibiotics which include β-lactam
ring [2]. ESBLs are able to hydrolyze penicillins,
cephalosporins of the first, second, third and fourth
generation. In addition, they are capable of hydroly-
zing monobactam, but not cephamycins or carbape-
nems. Moreover, ESBLs are easily inhibited by the β-
lactamase inhibitors such as clavulanic acid or sulbac-
tam [3]. 
As extended spectrum β-lactamases constitute a
wide group of enzymes likewise genes number which
expression is necessary for synthesis of appropriate
enzymes. A range group of genes responsible for
ESBLs synthesis belong mainly into blaSHV and
blaTEM families [4]. ESBLs are common identified
among clinical Enterobacteriaceae, frequently in
Klebsiella pneumoniae. Klebsiella pneumoniae resist-
ance to β-lactam antibiotics caused by ESBLs produc-
tion is important problem in treatment of infections
[5]. β-lactam antibiotics because of high efficacy and
low toxicity were frequently used in therapy. Nowa-
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days in connection with the fact that penicillins,
cephalosporines and carbapenems are included in sub-
strate spectrum of ESBLs a significant restriction of
therapeutic possibilities for use of these antibiotics has
been observed [6]. 
The aim of this study was to analyze the presence
of blaSHV genes in Klebsiella pneumoniae strains using
genetically methods. An attempt to define the most fre-
quent profiles of phenotype resistance to antibiotics
other than β-lactams in Klebsiella pneumoniae ESBLs
producers has been undertaken. Moreover, we try to
establish a relationship between antibiotic susceptibi-
lity patterns and presence of particular blaSHV genes in
Klebsiella pneumoniae strains. 
Materials and methods
Bacterial isolates. Twenty five strains of Klebsiela pneumoniae
isolated from clinical specimens of patients hospitalized at the
University Hospital in Bialystok (Poland) were included in this
study. Identification of the strains was performed with using rapid
ID 32 E strips for identification in ATB automated system
(BioMerieux). Control strains used in this study included Klebsiel-
la pneumoniae ATCC 700603, Escherichia coli ATCC 35218 and
Escherichia coli ATCC 25922.
Antibiotic susceptibility. The minimal inhibitory concentrations
(MICs) of antibiotics were determined in Mueller-Hinton broth by
a microdilution method according to the recommendations of CLSI
(Clinical and Laboratory Standards Institute) [7]. MICs of the fol-
lowing antibiotics were tested: gentamicin, (Gentamycin TZF,
Polfa-Tarchomin), ciprofloxacin (Ciprinol, Krka), tetracycline
(Sigma), tigecycline (Tygacil, Wyeth Pharmaceuticals). The range
of antibiotics concentrations used in the study were from 0.032
μg/ml to 512 μg/ml. 
Screening of ESBL-producing isolates. ESBLs production was
screened by the DDST method (double-disc diffusion test) accord-
ing with CLSI (Clinical and Laboratory Standards Institute) rec-
ommendations [7]. Tests were performed on Mueller-Hinton agar
(Oxoid) with using 30μg antibiotic discs of ceftazidime, cefo-
taxime, cefepime and aztreonam placed 20 mm from discs con-
taining 30μg of amoxicillin/clavulanic acid (Becton, Dickinson
and Company). A positive result of test was indicated by changes
of the inhibition zones.
Plasmid DNA isolation. Klebsiella pneumoniae strains were cul-
tured overnight on TSB (Trypticase Soy Broth, Emapol) at 37°C
and plasmids DNA extraction from Klebsiella pneumoniae isolates
was performed with the Plasmid Mini (A&A Biotechnology, Gdy-
nia, Poland) according to the manufacturer's instruction.
Molecular detection of the blaSHV genes. PCR assays were car-
ried out with the Cyclone 96 (PEQLAB Biotechnology, GmbH)
thermal cycler. PCR amplification of the blaSHV genes was per-
formed using the oligonucleotide primers designed on the basis of
the nucleotide sequence reported in the National Center for
Biotechnology Information (NCBI) GenBank database. Primers
used in PCR amplification: forward primer: blaSHVf 5'-
CCCGCAGCCGCTTGAGCAAA-3' and reverse primer: blaSHVr
5'-CATGCTCGCCGGCGTATCCC-3'. The PCR mixture, in a final
volume of 25 μl, contained: 10 pmol/μl of each primer (1μl), 12.5
μl of 2x PCR RED Master Mix (DNA-Gdansk), 3 μl of template
DNA and 7.5 μl of ultra pure H2O. The following conditions for
PCR amplification were used: denaturation at 94°C for 60 s,
annealing at 57°C for 60 s and extension at 72°C for 60 s repeated
for 35 cycles and final extension at 72°C for 10 min.
Detection of PCR products and sequence analysis. PCR ampli-
cons were separated electrophoretically at 5 V/cm for 90 min in
1.5% agarose gel containing 0.5 μg/ml of ethidium bromide in
TBE buffer and photographed using the Bio Rad ChemiDoc XRS
imaging system. Then, the positions of amplification products
were estimated with the position of the molecular weight marker. 
PCR products with a length of 733 bp were purified from the
agarose gel using Gel-Out kit (A&A Biotechnology, Gdynia,
Poland) and then sequenced using an Applied Biosystems model
3130xls Genetic Analyser. A nucleotide sequences from blaSHV
gene were analyzed and compared with sequences available in the
National Center for Biotechnology Information (NCBI) GenBank
database. 
Statistical analysis. Statistical analysis was performed with using
Statistica 8.0 (StatSoft) software. Values of p<0.05 were consid-
ered as statistically significant. 
Results and discussion
The aim of this study was to investigate an antibiotic
susceptibility of twenty five Klebsiella pneumoniae
strains which were defined as ESBL-producers based
on phenotypic test with using the double disc synergy
test. Minimal inhibitory concentrations of gentamicin,
ciprofloxacin, tetracycline and tigecycline were deter-
mined for all these strains. 
Among ESBL-producing isolates we observed 80%
isolates were susceptible to ciprofloxacin. Further-
more, all tested isolates showed a high rate of resis-
tance to gentamicin. Other investigators showed simi-
lar susceptibility of Klebsiella pneumoniae EBLs-pro-
ducers to ciprofloxacin and relationship between pro-
duction of ESBLs and resistance to aminoglycosides
[8 9]. Moreover, 68% of tested strains were suscepti-
bility to tetracycline. Additionally, in this study we
obtained high susceptibility of ESBLs-producers to
tigecycline. 88% of the isolates were susceptibility to
tigecycline. Other investigators describe such high
activity of tigecycline to Klebsiella pneumoniae
ESBLs-producers [10]. Statistical analysis reveal statis-
tically significant difference in the distribution of MICs
between follows antibiotics: tetracycline and
ciprofloxacin, tetracycline and gentamicin, cipro-
floxacin and gentamicin, tigecycline and gentamicin. It
is important to note that no statistically significant dif-
ference was observed between distribution of tetracy-
cline and tigecycline MIC values, but low MIC50 and
MIC90 values of tigecycline may indicate on high
activity of this antibiotic on ESBLs-producers.  
Because of high variety of blaSHV genes family it
was interesting to determine what variants of these
genes were carried by tested Klebsiella pneumoniae
strains [11]. Therefore, in the next part of this study a
sequencing of amplicons was carried out. 
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Genetic study revealed, that among strains of Kleb-
siella pneumoniae with phenotypic confirmatory pro-
duction of ESBLs, extended spectrum β-lactamases-
encoding blaSHV genes were present. The sequencing
showed that the majority of DNA isolates from ESBLs
producers carried blaSHV-5 genes (eight strains), seven
isolates contained blaSHV-2 genes, six strains carried
blaSHV-18 genes. Moreover, two isolates contained
genes for SHV-7 and two others for SHV-12. Epi-
demiological survey in Europe show that the most fre-
quent blaSHV genes responsible for extended spectrumβ-lactamases production are blaSHV-5, blaSHV-12,
blaSHV-2 [12,13].
We investigate relationship between antibiotic sus-
ceptibility and the presence of SHV types. In the case
of SHV-2 ESBLs isolates, resistance rates were as fol-
lows: tigecycline 14%, cirofloxacin 14%, gentamicin
100% and tetracycline 57%. All the SHV-5 ESBLs-
producing Klebsiella pneumoniae strains were suscep-
tible to tigecycline (87.5%), ciprofloxacin (75%), and
tetracycline (87.5%). All strains carrying blaSHV-7 gene
were susceptible to tigecycline and tetracycline and
resistant to ciprofloxacin and gentamicin. Reported
isolates possessing the ESBLs SHV-12 were suscepti-
ble to tigecycline, ciprofloxacin and tetracycline and
resistant to gentamicinan. Additionally, isolates carry-
ing blaSHV-18 were susceptible to ciprofloxacin
(100%), tetracycline (83%), tigecycline (83%) and
resistance to gentamicin (100%). 
It is well known that SHV enzymes are distributed
worldwide. Moreover, genes encoded ESBLs are
mainly carried by easily transferable plasmids, which
allows for quick spreading of ESBLs among strains of
Gram-negative rods. blaSHV genes encoding for
ESBLs predominantly have been found in Klebsiella
pneumoniae but in case of its presence on plasmids
there is a very high risk of its transmission [14]. They
were detected in Escherichia coli, Salmonella ssp, and
S. enterica. ESBLs also have been reported in 
S. marcescens and E. cloacae [15]. 
Numerous infection caused by organisms produ-
cing ESBLs have been observed worldwide. The pre-
sence of resistance connected with of extended spec-
trum β-lactamases production in bacteria may lead to
serious therapeutic implications in infections caused
by these organisms. As mentioned above, ESBLs are
responsible for higher levels of resistance to extended
spectrum cephalosporins. Results of our study reveal
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Table 1. Distribution of  minimal inhibitory concentrations of tetracycline, ciprofloxacin, gentamicin and tigecycline in Klebsiella pneumo-
niae ESBL (+) strains. The percentage of ESBLs-producing strains which were susceptible, intermediate and resistant to tested antibiotics. 
Abbreviations: MIC – minimal inhibitory concentration; MIC50 – minimal inhibitory concentration required to inhibit the growth of 50% of organisms;
MIC90 – minimal inhibitory concentration required to inhibit the growth of 90% of organisms; S – susceptible; I – intermediate; R – resistant. 
Table 2. The presence of blaSHV genes responsible for production of particular extended spectrum β-lactamases from SHV family in
strains of Klebsiella pneumoniae ESBL-producers. 
Abbreviations: n – number of strains; TG – tigecycline; CIP – ciprofloxacin; TC – tetracycline; GM – gentamicin. S – susceptible; I – intermediate; 
R – resistant. 
that tigecycline seems to be an opportunity in antibio-
tic choices for infections caused by ESBLs-producing
gram-negative rods.
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